Matthew Shair, Director at Nuvalent, Inc. (NUVL), sold 120,000 shares at $100.27 ($12.0M) on 2025-10-28, disclosed to the SEC on 2025-10-29.
Scheduled sale ($12.0M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $100.23 | 4,046 | $406K | 3.4% |
| 2 | $100.23 | 4,046 | $406K | 3.4% |
| 3 | $100.23 | 14,345 | $1.4M | 12.0% |
| 4 | $100.23 | 14,345 | $1.4M | 12.0% |
| 5 | $100.27 | 9,154 | $918K | 7.6% |
| 6 | $100.27 | 9,154 |
| $918K |
| 7.6% |
| 7 | $100.27 | 32,455 | $3.3M | 27.0% |
| 8 | $100.27 | 32,455 | $3.3M | 27.0% |
| Total | $100.26 avg | 120,000 | $12.0M | 100% |
| Filing → |
| NUVL | SELL | 2025-01-29 | $302K | — | Filing → |
| NUVL | SELL | 2024-12-26 | $285K | — | Filing → |
| NUVL | SELL | 2024-11-27 | $382K | — | Filing → |